Novel MOAs in Wet AMD

The pipeline is full of therapies that hold promise for extending treatment efficacy.

Lejla Vajzovic, MD, FASRS; Robert L. Avery, MD; Carl D. Regillo, MD; and Durga S. Borkar, MD, MMCi

Drug Interactions in Immunosuppressive Therapy for Uveitis

A review of the toxic relationships to avoid when managing patients with uveitis.

Ioannis Papasavvas, MD, and Carl P. Herbort, Jr, MD, PD

Angiogenesis 2026: Highlights

New data on wet and dry AMD therapies, AI, and more.

Alex Brodin, MA, Senior Editor, and Rebecca Hepp, MA, Editor-in-Chief

The AMD Space Race

Allen C. Ho, MD; Robert L. Avery, MD; and Lejla Vajzovic, MD